The most influential people in biopharma in 2023

The times are changing in biopharma.

With the top drugmakers no longer committing most of their resources to the pandemic, biopharma is returning to its roots. But it’s clear the world is quickly changing, and so too are the companies that make up our industry.

Big Pharma companies are shuffling CEOs. Drugmakers are tapping AI to assist with drug development. Diversity in clinical trial participants and executive teams has become a top priority. Venture investors are contending with a more risk-averse world.

But, as always, new medicines are making their way through clinical testing and onto the market. That’s one constant that doesn’t change in this field.

We hope our selections for this year’s Most Influential People in Biopharma special report reflect many of the trends our readers are seeing in their daily lives.







This is a unique website which will require a more modern browser to work!

Please upgrade today!